Risk factors of pituitary disorders following traumatic brain injury
François Lauzier(Victim Support), AF Turgeon(Hôpital de l'Enfant-Jésus), Amélie Boutin, Michèle Shemilt(The Quebec Population Health Research Network), François Lamontagne(Université de Sherbrooke), Patrick Archambault(Université Laval), Lynne Moore, Blake Senay(Université Laval), Isabelle Côté(The Quebec Population Health Research Network), Claudia Gagnon(Université Laval), Olivier Lachance(The Quebec Population Health Research Network), Françis Bernard(Hôpital du Sacré-Cœur de Montréal)
Cited by 0
Related Papers
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
|JAMA|2020|884
Mortality associated with withdrawal of life-sustaining therapy for patients with severe traumatic brain injury: a Canadian multicentre cohort study
|Canadian Medical Association Journal|2011|488
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design
|Annals of the American Thoracic Society|2020|449
Clinical Presentation of Patients with Ebola Virus Disease in Conakry, Guinea
|New England Journal of Medicine|2014|389